Amsacrine
Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
Product Specifications
CAS Number
51264-14-3
Product Name Alternative
M-AMSA; acridinyl anisidide
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335, H350, H360
Target
Autophagy; Topoisomerase
Type
Reference compound
Related Pathways
Autophagy; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Amsacrine.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CS(=O)(NC1=CC=C(NC2=C(C=CC=C3)C3=NC4=CC=CC=C42)C(OC)=C1)=O
Molecular Formula
C21H19N3O3S
Molecular Weight
393.46
Precautions
H302, H315, H319, H335, H350, H360
References & Citations
[1]Thomas D, et al. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. Br J Pharmacol. 2004 Jun;142 (3) :485-94.|[2]Attia SM. Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells. J Appl Toxicol. 2013 Jun;33 (6) :426-33.|[3]Kao-Shan CS, et al. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro. Cancer Treat Rep. 1984 Jul-Aug;68 (7-8) :989-97.|[4]Lee YC, et al. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Apoptosis. 2016 Oct 19
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Topo II
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BPIP-523 1 Unit
Variable Volume Single Channel Micropipette BPIP-523
Sign In for Pricing
View Details 
BNC942378-100 1x 100 µL
P21WAF1 (Tumor Suppressor Protein) (AC8), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details